[Neurostimulation system for cluster headache]
Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
Record ID 32015000953
German
Authors' objectives:
Custer headache (CH) is a primary headache disorder, which is characterised by mainly short-term, recurrent, severe unilateral pain with accompanying autonomic symptoms. A small amount of cluster headache patients (1 %), especially those with chronic cluster headache (CCH) is therapy-resistant. The stimulation of the Sphenopalatine Ganglion (SPG), besides various invasive and minimally invasive operative procedures, is a new treatment method for these patients. The aim of our systematic review is to compare the efficacy
and safety of the SPG stimulation of patients with therapy-resistant cluster headache with no treatment.
Authors' recommendations:
The available evidence is not sufficient to demonstrate superiority of the SPG stimulation for patients with therapy-resistant cluster headache compared to no treatment. New studies may have an impact on the estimate of effect. We propose a re-evaluation when further results from RCTs are available (probably in 2019). At present, the inclusion of SPG stimulation into the hospital benefit catalogue is not recommended.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://eprints.hta.lbg.ac.at/1062/1/DSD_86.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Austria
MeSH Terms
- Cluster Headache
- Deep Brain Stimulation
- Hypothalamus
Contact
Organisation Name:
Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address:
Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name:
tarquin.mittermayr@aihta.at
Contact Email:
office@aihta.at
Copyright:
Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.